Effects of dopamine metabolites on locomotor activities and on the binding of dopamine: Relevance to the side effects of L-dopa

Life Sciences

Volumn 66, Issue 22, 2000, Pages 2159-2171

  Charlton, Clivel G ^a   Crowell Jr , Bernard ^a  

^a FLORIDA A AND M UNIVERSITY   (United States)

Author keywords

3,4 dimethoxyphenylethylamine; 3 methoxytyramine; Locomotor activity; Methylation

Indexed keywords

3 O METHYLDOPAMINE; CATECHOL METHYLTRANSFERASE; DOPAMINE; DOPAMINE RECEPTOR; DRUG METABOLITE; HOMOVERATRYLAMINE; LEVODOPA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DOPAMINE METABOLISM; DRUG EFFICACY; DRUG SAFETY; DYSKINESIA; LOCOMOTION; METHYLATION; NEUROTRANSMISSION; NONHUMAN; PARKINSON DISEASE;

ANIMALIA;

EID: 0034697202     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0024-3205(00)00543-9     Document Type: Article

References (49)

1. M.M. Mouradian, J.L. Juncos, G. Fabbrini and T.N. Chase, Ann. Neurol. 22 475-479 (1987).
2. M. Mouradian, J.L. Juncos, G. Fabbrini, J. Schlegel, J.J. Bartko and T.N. Chase, Ann. Neurol 24 372-378 (1988).
3. M.M. Mouradian, I.J.E. Heuser, F. Baronti and T.N. Chase, Ann. Neurol, 27 18-23 (1990).
4. T.N. Chase, M.M. Mouradian, T.M. Engber, Neurology, 43 (suppl 6) S23-S26 (1993).
5. N.P. Quinn, M.H. Marion, and C.D. Marsden, Eur. Neurol 27 (suppl.1) 105-113 (1987).
6. C.C. Marsden and J.D. Parkes, Lancet 1 292-296 (1976).
7. R.J. Hardie, A.J. Lees and G.M. Stern, Brain 107 487-506 (1984).
8. Quinn, J.D. Parkes and C.D. Marsden, Neurology 34 1131-1136 (1984).
9. J. L. Juncus, G. Fabbrini, M. M. Mouradian, C. Serrati, A.M. Kask and T.N. Chase, J. Neurosurg. Psychiatry 50 194-198 (1987).
10. J.D. Nutt and W.R. Woodward, Neurology 36(suppl.1) 98 (1986 )
11. W.H. Poewe, A.J.Lee, G.M. Stern, Neurology, 36 1528-1530 (1986).
12. I. Shoulson, G.A. Glaubiger and T.N. Chase, Neurology 25 1144-1148 (1975).
13. R.J. Hardie, A.J. Lees, G.M. Stern, Brain 107 487-506 (1986).
14. J.A.Obeso, M.R. Luquin and J.M. Martinez-Lange, Ann. Neurol 19 31-35 (1986).
15. C. Feuerstein, M. Tanche, F. Serre, M. Gavend, J. Pellat and j. Perret, Acta Neurol. Scandinav. 56 79-82 (1977) .
16. M.A. Mena, V. Muradas, E. Bazan, J. Reiriz and J.G. de Yebenes, Adv. Neurol. 45 481-486 (1986).
17. R.J. Hardie, A.J. Lees and G.M. Stern, Adv. Neurol. 45 487-492 (1986)
18. G. Fsbbrini, J.L. Juncos, M.M. Mouradian, S. Serrati and T.N. Chase, Neurology 37 856-859 (1997).
19. J.G. Nutt and J. H. Fellman. Clin. Neuropharmacol. 7(1) 35-49 (1984).
20. M.D. Muenter, N.S. Sharpless and G.M. Tyce. Mayo Clin Proc. 47 388-95 (1972)
21. L.Rivera-Calimlim, T. Deepak, R. Anderson and R. Joynt. Arch. Neurol. 34 228-32 (1977)
22. L.T. Kremzner, S. Berl, M. Mendoza and D. Yahr, Adv. Neurol. 2 79-89 (1973).
23. M.D. Meunter, N.S. Sharpless and G. Tyce, Adv. Neurol. 5 309-315 (1974).
24. N.S. Sharpless, M.D. Muenter, G.M. Tyce and C.A. Owen, Jr., Clin. Chim. Acta 37 359-369 (1972).
25. R. Benson, B. Crowell, B. Hill, K. Doomquah and C. Charlton, Neurochem. Res. 18(3) 325-330 (1993).
26. R. Benson, Ph.D Thesis, Meharry Medical College, Nashville (1992).
27. W. Zhao, D. Olsen, X. Liu, N. Lamango, C.Charlton, National Minority Research Symposium, Abst. C33 p51 (1998).
28. E. Melamed, M. Globus, A. Uzzan, Neurology 35(1) 118 (1985).
29. E. Melamed, Adv. Neurol. 53 61-66 (1990).
30. A. Barbeau, P. Singh, P. Gaudreau and M. Joubert, Can. Med. Asso J. 94 659 (1966).
31. A. Barbeau, J. Neurosurgery 24 162-164 ( 1966)
32. M. Takesda, Y. Kakimoto, I. Sano and A. Kanero, Nature, Lond., 199 203-204 (1963).
33. A. Reches and S. Fahn, Ann. Neurol. 12 267-371 (1982).
34. A. Reches , L.R. Mielke and S. Fahn, Neurology 32 887-888 (1982)
35. M.K. Horne, C.H. Cheng and G.F. Wooten, Pharmacol. 28 12-26 (1984).
36. G.M. Everett and J.W. Borcherding, Science 164 849-850 (1970).
37. J. Axelrod and R. Tomchick, J. Biol. Chem. 233 702-707 (1958).
38. th Ed., p400, Macmillan Publishing Co. Inc., New York (1980) .
39. A.C. Williams, H.S. Pall, G.B. Steventon, S. Green, S. Bultrum and R.H. Waring, Adv Neurol. 60 194-196 (1993).
40. C.G. Charlton and B. Crowell, Jr. Mol. Chem. Neuropathol. 26(3) 269-281 (1995).
41. B.G.Crowell, Jr. R. Benson, D. Shockley and C. Charlton, Behav. Neural. Biol. 59 186-193 (1993).
42. M.A. Collins, E.J. Neafsey, K. Matsubara, R.J. Cobuzzi and H. Rollema, Brain Res. 570 154-160 (1992).
43. K. Matsubara, T. Gonda, H. Sawada, T. Uezona, Y. Kobayashi, T. Kawamura, K. Ohtaki, K. Kimura and A. Akaike, J. Neurochem. 70 (2) 727-735 (1998).
44. R.J. Wurtman, C. Chou and C. Rose, J. Pharmacol. Exprl. Ther. 174 351-362 (1970).
45. D.B. Calne, F. Karoum, C.R. Ruthven, M. Sandler, Brit. J. Pharmacol. 37 57-64 (1969).
46. O. Hornykiewicz, Life Sci. 15 1249-1259 (1974).
47. Bartholini, G, Kuruma, and A Pletscher, Brit. J. Pharmacol. 40 461-467 (1970)
48. M. Kajita, T. Niwa, N. Takeda, H. Yoshizumi, A. Tatematsu, K. Watanabe and T. Nagatsu, J. Chromatogr. 613 1-8 (1993).
49. T. Nagatsu and M. Yoshida, Neurosci. Lett., 87 178-182 (1988).